[Molecular pathology and therapeutics in Alzheimer's disease: amyloid beta-protein as a therapeutic target].
Ohyagi
Yasumasa
Y
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University.
D000544:Alzheimer Disease / Q000235:genetics* / Q000628:therapy*; D023582:Alzheimer Vaccines / Q000627:therapeutic use; D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors; D016229:Amyloid beta-Peptides / Q000276:immunology / Q000378:metabolism / Q000633:toxicity; D000818:Animals; D001058:Apomorphine / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans
D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides; D004791:Enzyme Inhibitors; D053829:Amyloid Precursor Protein Secretases; D001058:Apomorphine